1. Bluestein HG (1984) Antineuronal antibodies in the pathogenesis of neuropsychiatric manifestations of systemic lupus erythematosus. In: Behan P, Spreafico F (eds) Neuroimmunology. Raven Press, New York, pp 157–165
2. Carvey PM, Kroin JS, Zhang TJ, O’Dorisio TM, Yaksch TL, McRae A, Dahlstrom A, Kao LC, Goetz CG, Tanner CM, Shannon KM, Klawans HL (1988) Biochemical and immunochemical characterization of ventricular CSF from Parkinson’s disease patients with adrenal medulla transplants. Neurology 38 [Suppl 1]: 144
3. Chapman J, Korczyn AD, Hareuveni M, Michaelson DM (1986) Antibodies to cholinergic cell bodies in Alzheimer’s disease. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer’s and Parkinson’s disease. Strategies for research and development. Plenum Press, New York, pp 329–336
4. Filit HM, Luine V, Reisberg B, Amador R, McEwen BS, Zabriske JB (1985) Studies of the specificity of autobrain antibodies in Alzheimer’s disease. In: Hutton JT, Kenny AD (eds) Senile dementia. Alan R Liss, New York, pp 307–336
5. Franceschi M, Comola M, Nemni R, Pinto P, Iannaccone S, Smirne S, Canal N (1988) Neuron-binding antibodies in Alzheimer’s disease and Down’s syndrome. Neurology 38 [Suppl 1]: 285